Adicet Bio, Inc. — Director's Dealing 2023

Jun 30, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2023-06-30

Reporting Person: DUBIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-30	Common Stock	P	5000	$2.3999	Acquired	10900	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $2.3997 to $2.3999, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the Securities and Exchange Commission staff upon request.